Enterprise Financial Services Corp
Change company Symbol lookup
Select an option...
EFSC Enterprise Financial Services Corp
CYPS Cyclo3pss Corp
CXW CoreCivic Inc
STM STMicroelectronics NV
NYT New York Times Co
SOS Sos Ltd
DDOC DERMADOCTOR, INC.
CLOV Clover Health Investments Corp
POL Polished.Com Inc
ENJYQ Legacy EJY Inc
Go

Financials : Banks | Small Cap Blend
Company profile

Enterprise Financial Services Corp (EFSC) is the holding company for Enterprise Bank & Trust (the Bank). The Bank offers banking and wealth management services to individuals and corporate customers across Arizona, California, Kansas, Missouri, Nevada and New Mexico. Its business objective is to generate attractive shareholder returns by providing comprehensive financial services primarily to privately-held businesses, their owner families, and other success-minded individuals. The Company offers a range of business and personal banking services, including wealth management services. Its lending services include commercial and industrial (C&I), commercial real estate (CRE), real estate construction and development, residential real estate, small business administration (SBA), and consumer and tax credit-related loan products. It offers a range of deposit products and a suite of treasury management and international trade services, along with its tax credit brokerage activities.

Closing Price
$51.78
Day's Change
-0.27 (-0.52%)
Bid
--
Ask
--
B/A Size
--
Day's High
52.08
Day's Low
51.50
Volume
(Below Average)
Volume:
79,659

10-day average volume:
96,254
79,659

KIROMIC DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Kiromic BioPharma, Inc. and Encourages Investors to Contact the Firm

9:00 pm ET September 30, 2022 (BusinessWire) Print

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Kiromic BioPharma, Inc. ("Kiromic" or the "Company") (NASDAQ: KRBP) in the United States district Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired Kiromic securities between June 25, 2021 and August 13, 2021, both dates inclusive, or pursuant to the Company's July 2, 2021 IPO (the "Class Period"). Investors have until October 4, 2022 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

The Complaint alleges that the Offering Documents failed to disclose that the FDA had, prior to the filing of the Registration Statement and Prospectus, imposed a clinical hold, and in fact, contained statements indicating that it had not. Given that the Offering closed on July 2, 2021, more than thirty (30) days after the Company submitted the IND applications for its two immunotherapy product candidates, investors were assured that no clinical hold had been issued and clinical trials would commence. The Company, however, had received communications from the FDA on June 16 and 17, 2021, informing it that the FDA was placing the IND applications for its two candidate products on clinical hold. The Offering Documents failed to disclose this information, instead representing that clinical testing was expected to proceed in the third quarter of 2021. Clinical testing did not proceed in the third quarter of 2021, nor was it likely given the FDA's imposition of a clinical hold.

If you purchased or otherwise acquired Kiromic shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Melissa Fortunato by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220930005662/en/

SOURCE: Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com 
www.bespc.com
comtex tracking

COMTEX_415654539/1006/2022-09-30T21:00:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.